Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.02B | 2.32B | 1.62B | 1.37B | 925.37M |
Gross Profit | 909.35M | 700.00M | 499.54M | 620.30M | 437.49M |
EBITDA | 375.05M | 429.90M | 324.22M | -62.75M | 119.11M |
Net Income | 306.78M | 252.20M | 180.85M | -507.07M | -255.75M |
Balance Sheet | |||||
Total Assets | 3.66B | 3.38B | 2.61B | 2.39B | 1.45B |
Cash, Cash Equivalents and Short-Term Investments | 1.14B | 1.33B | 1.02B | 1.03B | 357.33M |
Total Debt | 508.56M | 370.57M | 351.29M | 345.37M | 870.46M |
Total Liabilities | 1.28B | 1.07B | 891.49M | 842.39M | 2.58B |
Stockholders Equity | 2.38B | 2.30B | 1.72B | 1.55B | -1.13B |
Cash Flow | |||||
Free Cash Flow | 361.77M | 332.41M | 244.02M | 138.03M | 136.31M |
Operating Cash Flow | 452.37M | 410.14M | 281.00M | 187.75M | 154.90M |
Investing Cash Flow | -267.37M | -263.61M | -178.36M | -48.95M | -117.47M |
Financing Cash Flow | -375.19M | 157.50M | -138.08M | 638.57M | 76.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | HK$6.83B | 26.93 | 26.24% | 1.63% | 17.69% | 5.37% | |
70 Outperform | HK$9.22B | 14.70 | 9.30% | ― | 7.28% | -13.77% | |
70 Outperform | HK$8.10B | 25.02 | 13.13% | 2.41% | 28.02% | 19.41% | |
69 Neutral | HK$1.75B | 5.43 | 24.13% | 4.09% | -3.85% | -19.28% | |
66 Neutral | HK$601.91M | 36.22 | 1.07% | 8.89% | -1.20% | -87.51% | |
61 Neutral | HK$1.60B | ― | -6.55% | 0.51% | 0.04% | -4.88% | |
52 Neutral | $7.49B | 0.22 | -61.87% | 2.28% | 16.62% | 1.08% |
Gushengtang Holdings Limited announced the successful passing of all proposed resolutions during its Annual General Meeting held on June 20, 2025. The resolutions included the adoption of the audited financial statements for the year ended December 31, 2024, the re-election of certain directors, and the declaration of a final dividend of HK$0.41 per share. The meeting saw full participation from shareholders, with no abstentions or votes against the resolutions, indicating strong shareholder support and confidence in the company’s governance and future plans.
The most recent analyst rating on (HK:2273) stock is a Buy with a HK$65.00 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.
Gushengtang Holdings Limited has announced the composition of its board of directors, which includes executive, non-executive, and independent non-executive directors. The company has also established three committees: the Audit Committee, the Remuneration Committee, and the Nomination Committee, with specific directors assigned to each. This announcement provides clarity on the governance structure of the company, potentially impacting its decision-making processes and strategic direction.
The most recent analyst rating on (HK:2273) stock is a Buy with a HK$65.00 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.
Gushengtang Holdings Limited, through its wholly-owned subsidiary Gushengtang Singapore, has entered into a Share Subscription Agreement with Tu Health Care. Under this agreement, Tu Health Care will make a capital contribution of SGD1.6 million, resulting in Gushengtang Singapore being owned approximately 83.16% by Gushengtang Holdings and 16.84% by Tu Health Care. This transaction is classified as a connected transaction under Hong Kong’s Listing Rules, due to the relationship between Mr. Tu, a key executive of Gushengtang Holdings, and Tu Health Care.
The most recent analyst rating on (HK:2273) stock is a Buy with a HK$65.00 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.
Gushengtang Holdings Limited has announced its upcoming annual general meeting scheduled for June 20, 2025, in Guangzhou, PRC. Key agenda items include the adoption of the 2024 financial statements, re-election of directors, declaration of a final dividend of HK$0.41 per share, and re-appointment of Ernst & Young as auditors. The meeting will also consider resolutions to authorize the board to allot and issue additional shares, enhancing the company’s operational flexibility and potential for growth.
The most recent analyst rating on (HK:2273) stock is a Buy with a HK$65.00 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.
Gushengtang Holdings Limited, a company incorporated in the Cayman Islands, announced the retirement of Mr. Gao Jian, a non-executive director, who will not seek re-election at the upcoming annual general meeting on June 20, 2025. Mr. Gao is stepping down to focus on other business commitments, and his departure is amicable, with no disagreements with the board. The company expressed gratitude for his contributions during his tenure.
The most recent analyst rating on (HK:2273) stock is a Buy with a HK$42.00 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.
Gushengtang Holdings Limited, a company incorporated in the Cayman Islands, reported a significant increase in customer visits for the first quarter of 2025. The company experienced a 12.7% growth in customer visits compared to the same period in 2024, reaching approximately 1,210,000 visits. This growth indicates a positive trend in the company’s operations, potentially enhancing its market position and stakeholder confidence.